Patent: 8,637,473
✉ Email this page to a colleague
Summary for Patent: 8,637,473
| Title: | Synthetic membrane anchors |
| Abstract: | Synthetic molecule construct of the structure F-S1-S2-L where F is an O-linked mono-, di-, tri- or oligo-saccharide, S1 is 2-aminoethyl, 3-aminopropyl, 4-aminobutyl, or 5-aminopentyl, S2 is -CO(CH2)2CO-, -CO(CH2)3CO-, -CO(CH2)4CO- or -CO(CH2)5CO-, and L is a diacyl- or dialkyl-glycerophospholipid. |
| Inventor(s): | Nicolai Bovin, Lissa Gilliver, Stephen Henry, Elena Korchagina |
| Assignee: | Kode Biotech Ltd |
| Application Number: | US13/067,021 |
| Patent Claims: | see list of patent claims |
Details for Patent 8,637,473
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Sanofi-aventis U.s. Llc | TOUJEO | insulin glargine | Injection | 206538 | 25-Feb-15 | ⤷ Start Trial | 2031-05-03 |
| Sanofi-aventis U.s. Llc | TOUJEO | insulin glargine | Injection | 206538 | 26-Mar-18 | ⤷ Start Trial | 2031-05-03 |
| Sanofi-aventis U.s. Llc | ADMELOG | insulin lispro | Injection | 209196 | 11-Dec-17 | ⤷ Start Trial | 2031-05-03 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
International Patent Family for US Patent 8,637,473
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Australia | 2005223715 | ⤷ Start Trial |
| Australia | 2007293770 | ⤷ Start Trial |
| Australia | 2008244737 | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
